Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - CASH & EQUIVALENTS
Cash & Equivalents ALNY - Alnylam Pharmaceuticals, Inc.
127 M
LAST VALUE
-61.69%
2 YEAR CAGR
-25.32%
5 YEAR CAGR
-17.61%
10 YEAR CAGR